Ven Bio Partners LLC Elevation Oncology, Inc. Transaction History
Ven Bio Partners LLC
- $177 Million
- Q2 2024
A detailed history of Ven Bio Partners LLC transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Ven Bio Partners LLC holds 2,434,255 shares of ELEV stock, worth $1.44 Million. This represents 3.71% of its overall portfolio holdings.
Number of Shares
2,434,255
Previous 2,696,133
9.71%
Holding current value
$1.44 Million
Previous $13.8 Million
52.48%
% of portfolio
3.71%
Previous 5.41%
Shares
5 transactions
Others Institutions Holding ELEV
# of Institutions
81Shares Held
52MCall Options Held
700Put Options Held
2.1K-
Logos Global Management LP San Francisco, CA3.85MShares$2.27 Million0.98% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.6MShares$2.12 Million0.05% of portfolio
-
Tang Capital Management LLC San Diego, CA3.06MShares$1.81 Million1.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA2.96MShares$1.75 Million0.47% of portfolio
-
Aisling Capital Management LP New York, NY2.83MShares$1.67 Million3.35% of portfolio
About Elevation Oncology, Inc.
- Ticker ELEV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,300,900
- Market Cap $13.7M
- Description
- Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...